Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Tilray Inc buy melinda

Tilray Inc
Start price
€115.92
27.09.18 / 50%
Target price
€193.03
22.01.19
Performance (%)
-43.40%
End price
€65.61
22.01.19
Summary
This prediction ended on 22.01.19 with a price of €65.61. Massive losses of -43.40% were the result for the BUY prediction by melinda. melinda has 50% into this prediction

Tilray, Inc. is a Canadian-based pharmaceutical and cannabis company that is listed on the NASDAQ exchange under the ticker symbol TLRY. The company specializes in the research, cultivation, production, and distribution of medical cannabis products worldwide. Founded in 2013, Tilray has become one of the largest cannabis companies in the world with operations in North America, Europe, and Australia. The company's main areas of focus are medical research and development, consumer brands, as well as global distribution partnerships. As a publicly traded company, Tilray's stock price is subject to market fluctuations and investor sentiment towards the cannabis industry.

Performance without dividends (%)
Name 1w 1m 1y 3y
Tilray Inc -14.105% -14.105% -78.620% -
iShares Core DAX® 0.443% 0.771% 16.335% 15.985%
iShares Nasdaq 100 -0.150% 4.094% 36.047% 50.709%
iShares Nikkei 225® 2.566% 4.202% 15.033% 10.588%
iShares S&P 500 0.479% 2.881% 29.113% 45.053%

According to melinda what are the pros and cons of Tilray Inc for the foreseeable future?

Pros
Could be worthwhile Investment >10% per year
Cons

Comments by melinda for this prediction

In the thread Tilray Inc diskutieren
Prediction Buy
Perf. (%) -43.40%
Target price 193.028
Change
Ends at 22.01.19

SecteurProduits pharmaceutiques



Supreme Cannabis conclut et approuve et approuve Tilray, évalué à environ 9,3 millions de dollars
3h12 26 septembre 2018 - Par Tomi Kilgore 
Supreme Cannabis conclut et approuve et approuve avec Tilray évalué à environ 9,3 millions de dollars. Co. Inc. cannabis suprême, Au Canada basée, a annoncé sa filiale Que de 7Acres un mercredi accord Conclu d'Tilray Canada Avait Avec approvisionnement, filiale de Tilray Inc.  En de l'Entente Vertu de 12 mois le 1er octobre et Qui a debute la DonT Estimée à 12 millions est Valeur de dollars (7,3 millions de Canadiens de dollars), vous cannabis 7Acres à Tilray Canada fournira Séché les patients Verser de cannabis médical Principalement au Canada Soutenir. "Nous Sommes heureux de fournir des Produits de 7ACRES aux Côtés de la qualité bien Connue et gamme de les patients Verser Tilray du monde existante ENTIER Soutenir" un Déclare le directeur général de cannabis Suprêmes John Fowler.  Les actions suprême cannabis de 37 Progresse Ont% Au Cours des Trois Vevak Derniers le FNB Que ALORS Horizons marijuana índice des Sciences de la Vie à 31% et le S &



métier
Logo Tilray Inc
Comme société tenue Fonctionne, ne pas les FILIALES à la consacre recherche, la culture, la transformation et la distribution de du cannabis médical

Tilray, Inc. lance des Dans Recherches,culture,production etdistribution du cannabis et cannabinoïdes médical.

Ses produits comprennent du cannabis séché et des extraits de cannabis.

La société a été fondée le 24 janvier 2018 et son siège à Nanaimo, au Canada.

Nombre d'employés  : 245 personnes.





melinda 
0
Report Share
27.09.18
Prediction Buy
Perf. (%) -43.40%
Target price 193.028
Change
Ends at 22.01.19

(Vom Mitglied beendet)

melinda 
0
Report Share
22.01.19

Stopped prediction by melinda for Tilray Inc

buy
Tilray Inc

Start price
Target price
Perf. (%)
€2.96
15.01.23
€3.50
15.01.24
-40.36%
16.01.24

Could be worthwhile Investment >10% per year
melinda 
15.01.23 50%
buy
Tilray Inc

Start price
Target price
Perf. (%)
€4.14
15.11.22
€6.00
15.11.23
-28.55%
15.01.23

Could be worthwhile Investment >10% per year
melinda 
15.11.22 20%
buy
Tilray Inc

Start price
Target price
Perf. (%)
€7.23
06.04.22
€10.00
06.04.23
-42.73%
15.11.22

Could be worthwhile Investment >10% per year
melinda 
06.04.22 50%
buy
Tilray Inc

Start price
Target price
Perf. (%)
€18.50
26.03.21
€28.00
26.03.22
-57.95%
28.03.22

Could be worthwhile Investment >10% per year
melinda 
26.03.21 50%
buy
Tilray Inc

Start price
Target price
Perf. (%)
€43.04
17.05.19
€83.89
04.11.21
-57.02%
26.03.21

Could be worthwhile Investment >10% per year
melinda 
18.08.19 50%
sell
Tilray Inc

Start price
Target price
Perf. (%)
€159.38
20.09.18
€135.30
25.09.18
-32.68%
25.09.18

Could be worthwhile Investment >10% per year
melinda 
18.08.19 50%
buy
Tilray Inc

Start price
Target price
Perf. (%)
€109.72
13.09.18
€180.40
17.09.18
-2.82%
17.09.18

Could be worthwhile Investment >10% per year
melinda 
18.08.19 50%
buy
Tilray Inc

Start price
Target price
Perf. (%)
€75.06
05.09.18
€83.89
05.09.18
13.84%
05.09.18

Could be worthwhile Investment >10% per year
melinda 
18.08.19 50%